Thermo Fisher Scientific Inc. launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, designed to automate and streamline workflows for immunology and immuno-oncology researchers. This new solution aims to provide more detailed and accurate insights from critical cellular samples with increased speed, versatility, and reliability.
Leveraging Thermo Fisher’s acoustic focusing technology, the Attune Xenith Flow Cytometer offers improved time to results for scientists researching cellular behaviors and mechanisms, and discovering targeted therapies. It supports both spectral unmixing and conventional flow cytometry, allowing researchers to tackle a broader range of applications with greater flexibility and sensitivity.
The system addresses common challenges in flow cytometry, such as complex data analysis, non-intuitive interfaces, and frequent clogs, through its user-friendly software and innovative features. This advancement reinforces Thermo Fisher Scientific’s commitment to providing innovative tools that enhance lab efficiency, data accuracy, and overall research capabilities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.